Rani Therapeutics Holdings (RANI) Non-Current Debt (2020 - 2025)
Historic Non-Current Debt for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q2 2025 value amounting to $2.2 million.
- Rani Therapeutics Holdings' Non-Current Debt fell 8704.6% to $2.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.2 million, marking a year-over-year decrease of 8704.6%. This contributed to the annual value of $9.6 million for FY2024, which is 6073.76% down from last year.
- According to the latest figures from Q2 2025, Rani Therapeutics Holdings' Non-Current Debt is $2.2 million, which was down 8704.6% from $5.9 million recorded in Q1 2025.
- Over the past 5 years, Rani Therapeutics Holdings' Non-Current Debt peaked at $29.3 million during Q2 2023, and registered a low of $2.2 million during Q2 2025.
- Over the past 4 years, Rani Therapeutics Holdings' median Non-Current Debt value was $19.0 million (recorded in 2024), while the average stood at $18.6 million.
- In the last 5 years, Rani Therapeutics Holdings' Non-Current Debt soared by 9942.52% in 2023 and then crashed by 8704.6% in 2025.
- Over the past 4 years, Rani Therapeutics Holdings' Non-Current Debt (Quarter) stood at $29.1 million in 2022, then fell by 16.0% to $24.5 million in 2023, then plummeted by 60.74% to $9.6 million in 2024, then tumbled by 76.81% to $2.2 million in 2025.
- Its Non-Current Debt stands at $2.2 million for Q2 2025, versus $5.9 million for Q1 2025 and $9.6 million for Q4 2024.